Germany to India: Syringe Import Trade Route

The Germany to India Syringe corridor is one of India's established pharmaceutical import routes from Germany, with 820 shipments documented worth a combined $138.4B USD. The route is dominated by GLAXOSMITHKLINE BIOLOGICALS SA , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Germany's syringe export sector.

Across 72 active Germany suppliers, the average shipment value stands at $168.8M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 11.7%, placing it at rank #15 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED , ROCHE PRODUCTS (INDIA) PRIVATE LIMITED , NOVARTIS HEALTHCARE PRIVATE LIMITED and 50 others. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED is the single largest Indian importer with 4 shipments valued at $138.0B USD.

India's syringe imports from Germany are driven primarily by a handful of large-scale Germany manufacturers. GLAXOSMITHKLINE BIOLOGICALS SA with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 72 active exporters signals a competitive but concentrated market — Indian buyers benefit from Germany supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAXOSMITHKLINE BIOLOGICALS SA , F. HOFFMANN -LA ROCHE LTD , NOVARTIS PHARMA AG — together account for 100% of total trade value on this route. The average shipment value of $168.8M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as fluarix tetra vaccine (inactivated influenza vaccine) (splitvirion) i.p.(1 pfs[1 prefilled syringe single dose 0.5ml nh and actemra solution for injection in pre - filled syringe 162mg/0.9ml pre - filled syringe 1 (tocilizumab)(list 3 sr.no.1 , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Germany supplier.

On the buying side, GLAXOSMITHKLINE PHARMACEUTICALS LIMITED is the largest importer with 4 shipments worth $138.0B USD — representing 100% of all syringe imports from Germany on this route. A total of 53 buyers are active on this corridor.